Low-dose intravenous gammaglobulin in the treatment of severe autoimmune urticaria

BACKGROUND: An autoimmune pathogenic mechanism is implicated in about one-third of patients with chronic urticaria (CU), involving circulating functional autoantibodies to either the high affinity IgE receptor (LgG1/IgG3 anti-FcARI) or to IgE, with histamine releasing activity. New therapeutic appro...

ver descrição completa

Detalhes bibliográficos
Autor principal: Pereira, C (author)
Outros Autores: Tavares, B (author), Carrapatoso, I (author), Loureiro, G (author), Faria, E (author), Machado, D (author), Chieira, C (author)
Formato: article
Idioma:eng
Publicado em: 2012
Assuntos:
Imunoglobulinas Intravenosas
Urticária
Texto completo:http://hdl.handle.net/10400.4/1307
País:Portugal
Oai:oai:rihuc.huc.min-saude.pt:10400.4/1307

Texto Completo

http://hdl.handle.net/10400.4/1307

Registos relacionados